Vanzacaftor

Vanzacaftor

Vanzacaftor is a novel CFTR (Cystic fibrosis transmembrane conductance regulator) corrector.

Systematic Name

(14S)-8-[3-(2-Dispiro[2.0.24.13]Heptan-7-Ylethoxy)Pyrazol-1-Yl]-12,12-Dimethyl-2,2-Dioxo-2λ6-Thia-3,9,11,18,23-Pentazatetracyclo[17.3.1.111,14.05,10]Tetracosa-1(22),5(10),6,8,19(23),20-Hexaen-4-One

Brand Name(S)

N/A

Therapeutic Category

Cystic fibrosis

Suitable Formulations

Solid

Approvals

U/Development

Do You Have A Question? Lets Have A Talk

Sthree chemicals is a pure-play API manufacturer with a diverse portfolio of capabilities in delivering efficiencies to generic players globally. Founded in 2012 by a team with vast experience across the pharmaceutical value chain, the company is on a mission to become the most preferred partner for pharmaceuticals.